Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Mallinckrodt
Moodys
Julphar
UBS
Colorcon
US Army
Queensland Health

Generated: April 22, 2018

DrugPatentWatch Database Preview

Chartwell Rx Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has forty-seven approved drugs.



Summary for Chartwell Rx
US Patents:0
Tradenames:25
Ingredients:22
NDAs:47

Drugs and US Patents for Chartwell Rx

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088847-001 Feb 26, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx FULVICIN-U/F griseofulvin, microcrystalline TABLET;ORAL 060569-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx CILOSTAZOL cilostazol TABLET;ORAL 077722-001 Sep 24, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 088625-001 Aug 23, 1984 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
UBS
AstraZeneca
Express Scripts
Accenture
Cantor Fitzgerald
Baxter
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.